Cite
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study
MLA
Marie-Therese Rubio, et al. “Outcomes in Patients Treated with Chimeric Antigen Receptor T-Cell Therapy Who Were Admitted to Intensive Care (CARTTAS): An International, Multicentre, Observational Cohort Study.” Lancet Haematology, vol. 8, Jan. 2021, pp. E355–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10e0221bac10970ab09383fbb48e5504&authtype=sso&custid=ns315887.
APA
Marie-Therese Rubio, Roberta Di Blasi, Gilles Salles, Miguel A Perales, Kada Klouche, Muriel Picard, Pierre Sesques, Eric Mariotte, Michael Darmon, Boris Böll, Philippe R. Bauer, Sanjay Chawla, Kevin Rakszawski, Nahema Issa, Anne Huynh, Guillaume Cartron, Florence Rabian, Peter Borchmann, Michael Joannidis, … Edouard Forcade. (2021). Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study. Lancet Haematology, 8, E355–E364.
Chicago
Marie-Therese Rubio, Roberta Di Blasi, Gilles Salles, Miguel A Perales, Kada Klouche, Muriel Picard, Pierre Sesques, et al. 2021. “Outcomes in Patients Treated with Chimeric Antigen Receptor T-Cell Therapy Who Were Admitted to Intensive Care (CARTTAS): An International, Multicentre, Observational Cohort Study.” Lancet Haematology 8 (January): E355–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10e0221bac10970ab09383fbb48e5504&authtype=sso&custid=ns315887.